Prochlorperazine Edisylate
PROCHLORPERAZINE EDISYLATE - prochlorperazine edisylate injection
Approved
Approval ID
ed9e300a-c577-4c78-a806-3a586ab5f1c7
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Sep 27, 2021
Manufacturers
FDA
Nexus Pharmaceuticals Inc.
DUNS: 620714787
FDA
Nexus Pharmaceuticals LLC
DUNS: 620714787
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Prochlorperazine Edisylate
PRODUCT DETAILS
NDC Product Code14789-700
Application NumberANDA204860
Marketing CategoryC73584
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateSeptember 27, 2021
Generic NameProchlorperazine Edisylate
INGREDIENTS (7)
Prochlorperazine EdisylateActive
Quantity: 5 mg in 1 mL
Code: PG20W5VQZS
Classification: ACTIM
SACCHARIN SODIUMInactive
Code: SB8ZUX40TY
Classification: IACT
BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT
SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORMInactive
Code: 3980JIH2SW
Classification: IACT
SODIUM TARTRATEInactive
Code: QTO9JB4MDD
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
PROCHLORPERAZINE EDISYLATEActive
Quantity: 5 mg in 1 mL
Code: PG20W5VQZS
Classification: ACTIM